General Information
Revision date
2013-11-18
Product name
FOX JM92 Advanced Suspension Fluid
Emergency telephone
800-633-8253
Icons in SDS
Company Information
company name
FOX Factory, Inc.
e-mail address of the competent person responsible for the Safety Data Sheet
oreng@ridefox.com750
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW
Appearance/Odor
Red liquid. Mild odor
Health hazards
No known immediate health hazards. High-pressure injection under the skin may cause serious damage
Physical hazards
No known physical hazards
NFPA Ratings
Health, Fire, Reactivity) 0, 1, 0
Hazard statements
Least - 0 Slight - 1 Moderate - 2 High - 3 Extreme - 4 Inhalation: Inhalation of vapors (generated at high temperatures only) or oil mist may cause mild irritation of the nose, throat, and respiratory tract. Eye Irritation: Lubricating oils are generally considered no more than minimally irritating to the eyes. Skin Contact: May cause slight irritation of the skin. If irritation occurs, a temporary burning sensation and minor redness and/or swelling may result. Release of the material during high-pressure applications may result in injection under the skin causing possible extensive tissue damage which is difficult to heal. Other adverse effects not expected from brief skin contact. Ingestion: Lubricating oils are generally no more than slightly toxic if swallowed.
Other Health Effects
The International Agency for Research on Cancer (IARC) has determined there is sufficient evidence for the carcinogenicity in experimental animals of used gasoline motor oils. Handling procedures and safety precautions in the MSDS should be followed to minimize exposure to the used product. Signs and Symptoms: Irritation as noted above. Aspiration pneumonitis may be evidenced by coughing, labored breathing and cyanosis (bluish skin); in severe cases death may occur.
Medical Conditions Generally Aggravated by Exposure
Pre-existing eye, skin and respiratory disorders may be aggravated by exposure to this product. For additional health information, refer to section 11.